Bajin Wei
Overview
Explore the profile of Bajin Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong G, Shen Q, Zheng X, Yu K, Lu H, Wei B, et al.
J Transl Med
. 2024 Dec;
22(1):1149.
PMID: 39731153
Background: Aberrant alternative splicing (AS) contributes to tumor progression. A crucial component of AS is cleavage and polyadenylation specificity factor 4 (CPSF4). It remains unclear whether CPSF4 plays a role...
2.
Wei B, Yang F, Yu L, Qiu C
Cell Mol Biol Lett
. 2024 Aug;
29(1):107.
PMID: 39127633
Breast cancer represents the most prevalent tumor type and a foremost cause of mortality among women globally. The complex pathophysiological processes of breast cancer tumorigenesis and progression are regulated by...
3.
Wei B, Lou W
Noncoding RNA Res
. 2023 Dec;
9(1):55-65.
PMID: 38075197
Sorafenib resistance is a major obstacle influencing its therapeutic efficacy in advanced hepatocellular carcinoma (HCC). The knowledge of circular RNAs (circRNAs), a group of novel endogenous non-coding RNAs, in sorafenib...
4.
Wei B, Xiao S, Lou W
Heliyon
. 2023 Nov;
9(11):e21688.
PMID: 37954397
Liver metastasis is the main lethal cause of colorectal cancer (CRC). The knowledge of role and mechanism of circular RNA (circRNA) in liver metastasis of CRC is still inadequate. In...
5.
Zhong G, Song D, Lou W, Wei B, Chen Y, Cui H, et al.
Eur J Surg Oncol
. 2023 Jun;
49(11):106970.
PMID: 37365055
Background: The interest in breast cancer with low HER2 expression as a distinct subtype is increasing. We aimed to explore the differences between HER2-low and HER2-zero breast cancer in their...
6.
Li Y, Zheng J, Deng Y, Deng X, Lou W, Wei B, et al.
Front Oncol
. 2022 Jun;
12:891824.
PMID: 35756641
Introduction: This study aimed to describe the latest epidemiology of female breast cancer globally, analyze the change pattern of the incidence rates and the disease's association with age, period, and...
7.
Wu Y, Deng Y, Wei B, Xiang D, Hu J, Zhao P, et al.
J Adv Res
. 2022 Jun;
40:233-247.
PMID: 35700919
Introduction: Cancer is the leading cause of death among children. Objectives: We report on the latest estimates of the burden of cancer among children at the global, regional, and national...
8.
Wei B, Chen H, Chen X, Guo D, Hong L, Zheng S
Front Oncol
. 2022 Apr;
12:842312.
PMID: 35392235
The expression of the SRY-Box Transcription Factor 15 (Sox15) is reduced by DNA methylation, and its progression is suppressed within numerous tumors. However, its effect on hepatocellular carcinoma (HCC) remains...
9.
Deng Y, Xie Y, Wang M, Xu P, Wei B, Li N, et al.
Front Pharmacol
. 2022 Jan;
12:670657.
PMID: 35087400
Antihypertensive drugs might play a key role in the risk and poor prognosis of colorectal cancer. However, current epidemiologic evidence remains inconsistent. The aim of this study is to quantify...
10.
Deng Y, Li H, Zheng Y, Zhai Z, Wang M, Lin S, et al.
Front Oncol
. 2021 Dec;
11:779185.
PMID: 34888251
Background: The treatment for locally advanced breast cancer (LABC) is a severe clinical problem. The postoperative radiotherapy is a conventional treatment method for patients with LABC, whereas the effect of...